SQUAMOUS CELL CANCER OF THE HEAD AND NECK

Clinical trials for SQUAMOUS CELL CANCER OF THE HEAD AND NECK explained in plain language.

Never miss a new study

Get alerted when new SQUAMOUS CELL CANCER OF THE HEAD AND NECK trials appear

Sign up with your email to follow new studies for SQUAMOUS CELL CANCER OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cancer drug trial tests immune system 'Decoy' to fight advanced tumors

Disease control Ongoing

This early-stage study is testing a new immunotherapy drug called DECOY20, both alone and combined with another cancer drug (tislelizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses, check for s…

Matched conditions: SQUAMOUS CELL CANCER OF THE HEAD AND NECK

Phase: PHASE1, PHASE2 • Sponsor: Indaptus Therapeutics, Inc • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

SQUAMOUS CELL CANCER OF THE HEAD AND NECK

Get alerted when new SQUAMOUS CELL CANCER OF THE HEAD AND NECK trials appear

New cancer drug trial tests immune system 'Decoy' to fight advanced tumors